5Yuen M F, Chow D H, Tsui K, et al. Liver histology ofasian patients with chronic hepatitis B on prolonged lami- vudine therapy[J]. Aliment Pharmacol Ther, 2005, 21 (7) :841-849.
6Lau D T, Khokhar F, Doo E, et al. Long term therapy of chronic hepatitis B with lamivudine[J]. Hepatology, 2000,32(4 pt 1):828-834.
8Lai CL, Gan E E, Hsu C W, et al. Two year results from the globe trial in patients with hepatitis B: greater clinical and antiviral efficacy for elbivudine(LdT)vs lami- vudine[J]. Hepatology, 2006,44(4 Suppl 1):222A.
9Lai C L, Gane E, Liaw Y, et al. Telbivudine versus lamivudine in patients with chronic hepatitis B[J]. N En- gl J Med,2007,357(25) :2576-2588.
8Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量：1931
3Rehemann B, Nascimeni M. Immunology of hepatitis B virus and hepatitis C virus infection [ J 1. Nat Rev Immyno1,2005,5 (3) :215 - 229.
4Stroffolini T, Gaeta GB, Mele A. AASLD Practice Guidline Chronic Hepatitis B and HBV infection in Italy [ J ]. Hepatology, 2007,46 (2) :608 -609.
5Chang TT,Jia JD, Omata M. New therapies for chronic hepatitis B in-fection [ J ]. Liver International, 2006,26 ( Suvpl 2 ) : 30.
6Fasano M, Lampertico P, Marzano A, et al. HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis Bpatients on lamivudine therapy for over 5 years [ J]. J Hepatol, 2012,56(6) :1254.
7Jayakumar R, Joshi YK, Singh S. Laboratory evaluation of three regimens of treatment of chronic hepatitis B : tenofovir,entecavir and combination of lamivudine and adefovir [ J ]. J Lab Physicians,2012,4( 1) : 10.
8Liu M, Cai H, Yi W. Safety of telbivudine treatment for chronic hepatitis B for the entire pregnancy [ J ]. J Viral Hepat, 2013 ,20(1):65.
